Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 3 Randomised Controlled Trial of Vitamin D Supplementation to Reduce Risk and Severity of COVID-19 and Other Acute Respiratory Infections in the UK Population

NCT04579640 is registered in ClinicalTrials.gov with Queen Mary University of London as lead sponsor.

NCT NCT04579640
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04579640 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 3 Randomised Controlled Trial of Vitamin D Supplementation to Reduce Risk and Severity of COVID-19 and Other Acute Respiratory Infections in the UK Population
Lead sponsor
Queen Mary University of London
Phase
Phase 3
Overall status
Completed
Start date
October 27, 2020
Completion date
February 28, 2022
Enrollment
6,200 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute respiratory tract infection, covid19